Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline | Zendy

W. Kimryn Rathmell | Zendy; R. Bryan Rumble | Zendy; Peter J. Van Veldhuizen | Zendy; Hikmat AlAhmadie | Zendy; Hamid Emamekhoo | Zendy; Ralph J. Hauke | Zendy; Alexander V. Louie | Zendy; Matthew I. Milowsky | Zendy; Ana M. Molina | Zendy; Tracy L. Rose | Zendy; Shankar Siva | Zendy; Nicholas G. Zaorsky | Zendy; Tian Zhang | Zendy; Rubina Qamar | Zendy; Terry M. Kungel | Zendy; Bryan Lewis | Zendy; Eric A. Singer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline

Author(s) -

W. Kimryn Rathmell,

R. Bryan Rumble,

Peter J. Van Veldhuizen,

Hikmat AlAhmadie,

Hamid Emamekhoo,

Ralph J. Hauke,

Alexander V. Louie,

Matthew I. Milowsky,

Ana M. Molina,

Tracy L. Rose,

Shankar Siva,

Nicholas G. Zaorsky,

Tian Zhang,

Rubina Qamar,

Terry M. Kungel,

Bryan Lewis,

Eric A. Singer

Publication year - 2022

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.22.00868

Subject(s) - medicine , renal cell carcinoma , oncology , metastasectomy , sunitinib , asymptomatic , clear cell renal cell carcinoma , systemic therapy , guideline , pazopanib , kidney cancer , nephrectomy , cancer , metastasis , pathology , kidney , breast cancer

To provide recommendations for the management of patients with metastatic clear cell renal cell carcinoma (ccRCC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research